The Paris Biofoundry is at the DIM BioConvS SynBioTherapy Symposium 2024
The SynBioTherapy Symposium 2024, happening today November 27th, is held at the Learning Planet Institute in Paris. This event, organized by DIM BioConvS, serves as a pivotal gathering at the intersection of synthetic biology and biotherapies, exploring the transformative potential of these fields to address critical healthcare challenges.
As part of the event, Stéphane Lemaire, Director of the Paris Biofoundry, will take the stage to highlight the crucial role of biofoundries in advancing therapeutic research. His talk will delve into the innovative capabilities of biofoundries, particularly their ability to accelerate the design, testing, and production of biotherapeutic solutions. Through a combination of automation, data-driven design, and cutting-edge experimental tools, biofoundries like the Paris Biofoundry empower researchers to overcome the traditional limitations of biotech development.
This symposium will bring together prominent international experts to share insights into the latest breakthroughs in the application of synthetic biology to therapeutics. Notable speakers such as Velia Siciliano, Head of Synthetic Biology and Systems for Biomedicine at IIT Naples, and Filippo Menolascina, Director of the Engineering Biology Centre at the University of Edinburgh, will present on topics ranging from gene therapy to the engineering of mammalian cells for therapeutic use. These discussions will highlight the intersection of biotechnological advancements and real-world clinical applications, with a focus on microbiome-centered biotherapies, an emerging field with great promise for treating a range of diseases.
The event will also provide attendees with ample opportunities for networking and collaboration. Interactive sessions, roundtable discussions, and opportunities to connect with researchers from around the world will enable participants to explore the synergies between synthetic biology, biotherapy, and the broader healthcare industry.
The Paris Biofoundry, as an active player in synthetic biology, continues to foster innovation and facilitate collaboration across international research communities. Its participation in such events underlines its commitment to addressing global health challenges and advancing biotechnological solutions. By leveraging the latest advancements in automation, data science, and experimental technologies, biofoundries are poised to redefine the future of healthcare and therapeutic development.
As synthetic biology and biotherapy continue to evolve, the SynBioTherapy Symposium 2024 provides an invaluable platform for researchers, biotechnologists, and medical professionals to stay at the forefront of these dynamic fields. The event promises to be a significant milestone in driving the next wave of biotechnological innovation, ensuring that both synthetic biology and biotherapies can be applied to solve some of the world’s most pressing health issues.
No responses yet